• 25961 Citations
  • 64 h-Index
1986 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

2020

Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer

Marks, D. K., Gartrell, R. D., El Asmar, M., Boboila, S., Hart, T., Lu, Y., Pan, Q., Yu, J., Hibshoosh, H., Guo, H., Andreopoulou, E., Wiechmann, L., Crew, K., Sparano, J., Hershman, D., Connolly, E., Saenger, Y. & Kalinsky, K., Jun 16 2020, In : Frontiers in Oncology. 10, 968.

Research output: Contribution to journalArticle

Open Access

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

International Immuno-Oncology Biomarker Working Group, Dec 1 2020, In : npj Breast Cancer. 6, 1, 15.

Research output: Contribution to journalReview article

Open Access
2 Scopus citations

Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System

Mehta, V., Goel, S., Kabarriti, R., Cole, D., Goldfinger, M., Acuna-Villaorduna, A., Pradhan, K., Thota, R., Reissman, S., Sparano, J. A., Gartrell, B. A., Smith, R. V., Ohri, N., Garg, M., Racine, A. D., Kalnicki, S., Perez-Soler, R., Halmos, B. & Verma, A., Jul 1 2020, In : Cancer discovery. 10, 7, p. 935-941 7 p.

Research output: Contribution to journalArticle

Open Access
52 Scopus citations

Clinical Outcomes in Early Breast Cancer with a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial

Sparano, J. A., Gray, R. J., Makower, D. F., Albain, K. S., Saphner, T. J., Badve, S. S., Wagner, L. I., Kaklamani, V. G., Keane, M. M., Gomez, H. L., Reddy, P. S., Goggins, T. F., Mayer, I. A., Toppmeyer, D. L., Brufsky, A. M., Goetz, M. P., Berenberg, J. L., Mahalcioiu, C., Desbiens, C., Hayes, D. F. & 9 others, Dees, E. C., Geyer, C. E., Olson, J. A., Wood, W. C., Lively, T., Paik, S., Ellis, M. J., Abrams, J. & Sledge, G. W., Mar 2020, In : JAMA Oncology. 6, 3, p. 367-374 8 p.

Research output: Contribution to journalArticle

Open Access
13 Scopus citations

Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming Barriers

Lin, L. L., Lakomy, D. S., Chiao, E. Y., Strother, R. M., Wirth, M., Cesarman, E., Borok, M., Busakhala, N., Chibwesha, C. J., Chinula, L., Ndlovu, N., Orem, J., Phipps, W., Sewram, V., Vogt, S. L., Sparano, J. A., Mitsuyasu, R. T., Krown, S. E. & Gopal, S., Jul 1 2020, In : JCO global oncology. 6, p. 1134-1146 13 p.

Research output: Contribution to journalArticle

Open Access

Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx

Wagner, L. I., Gray, R. J., Sparano, J. A., Whelan, T. J., Garcia, S. F., Yanez, B., Tevaarwerk, A. J., Carlos, R. C., Albain, K. S., Olson, J. A., Goetz, M. P., Pritchard, K. I., Hayes, D. F., Geyer, C. E., Dees, E. C., McCaskill-Stevens, W. J., Minasian, L. M., Sledge, G. W. & Cella, D., Jun 10 2020, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 17, p. 1875-1886 12 p.

Research output: Contribution to journalArticle

1 Scopus citations

Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up

Pothuri, B., Brodsky, A. L., Sparano, J. A., Blank, S. V., Kim, M., Hershman, D. L., Tiersten, A., Kiesel, B. F., Beumer, J. H., Liebes, L. & Muggia, F., Apr 1 2020, In : Cancer Chemotherapy and Pharmacology. 85, 4, p. 741-751 11 p.

Research output: Contribution to journalArticle

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study

Wesolowski, R., Stover, D. G., Lustberg, M. B., Shoben, A., Zhao, M., Mrozek, E., Layman, R. M., Macrae, E., Duan, W., Zhang, J., Hall, N., Wright, C. L., Gillespie, S., Berger, M., Chalmers, J. J., Carey, A., Balasubramanian, P., Miller, B. L., Amaya, P., Andreopoulou, E. & 8 others, Sparano, J., Shapiro, C. L., Villalona-Calero, M. A., Geyer, S., Chen, A., Grever, M. R., Knopp, M. V. & Ramaswamy, B., Aug 1 2020, In : Oncologist. 25, 8, p. e1158-e1169

Research output: Contribution to journalArticle

Open Access

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

the International Immuno-Oncology Biomarker Working Group, Dec 1 2020, In : npj Breast Cancer. 6, 1, 17.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

The Contribution of Race to Breast Tumor Microenvironment Composition and Disease Progression

Kim, G., Pastoriza, J. M., Condeelis, J. S., Sparano, J. A., Filippou, P. S., Karagiannis, G. S. & Oktay, M. H., Jun 30 2020, In : Frontiers in Oncology. 10, 1022.

Research output: Contribution to journalReview article

Open Access

Validation of an automated quantitative digital pathology approach for scoring tmem, a prognostic biomarker for metastasis

Entenberg, D., Oktay, M. H., D’alfonso, T., Ginter, P. S., Robinson, B. D., Xue, X., Rohan, T. E., Sparano, J. A., Jones, J. G. & Condeelis, J. S., Apr 2020, In : Cancers. 12, 4, 846.

Research output: Contribution to journalArticle

Open Access
2019

Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay with Breast Ductal Carcinoma in Situ Treatment

Lehman, C. D., Gatsonis, C., Romanoff, J., Khan, S. A., Carlos, R., Solin, L. J., Badve, S., McCaskill-Stevens, W., Corsetti, R. L., Rahbar, H., Spell, D. W., Blankstein, K. B., Han, L. K., Sabol, J. L., Bumberry, J. R., Gareen, I., Snyder, B. S., Wagner, L. I., Miller, K. D., Sparano, J. A. & 1 others, Comstock, C., Jul 2019, In : JAMA Oncology. 5, 7, p. 1036-1042 7 p.

Research output: Contribution to journalArticle

5 Scopus citations

Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply

Sparano, J. A., Sep 26 2019, In : The New England journal of medicine. 381, 13, p. 1290-1291 2 p.

Research output: Contribution to journalLetter

Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer

Sparano, J. A., Gray, R. J., Ravdin, P. M., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Goetz, M. P., Olson, J. A., Lively, T., Badve, S. S., Saphner, T. J., Wagner, L. I., Whelan, T. J., Ellis, M. J., Paik, S., Wood, W. C., Keane, M. M. & 10 others, Gomez Moreno, H. L., Reddy, P. S., Goggins, T. F., Mayer, I. A., Brufsky, A. M., Toppmeyer, D. L., Kaklamani, V. G., Berenberg, J. L., Abrams, J. & Sledge, G. W., Jun 20 2019, In : New England Journal of Medicine. 380, 25, p. 2395-2405 11 p.

Research output: Contribution to journalArticle

64 Scopus citations

Current Landscape of Immunotherapy in Breast Cancer: A Review

Adams, S., Gatti-Mays, M. E., Kalinsky, K., Korde, L. A., Sharon, E., Amiri-Kordestani, L., Bear, H., McArthur, H. L., Frank, E., Perlmutter, J., Page, D. B., Vincent, B., Hayes, J. F., Gulley, J. L., Litton, J. K., Hortobagyi, G. N., Chia, S., Krop, I., White, J., Sparano, J. & 2 others, Disis, M. L. & Mittendorf, E. A., Aug 2019, In : JAMA Oncology. 5, 8, p. 1205-1214 10 p.

Research output: Contribution to journalReview article

33 Scopus citations

Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study

Yardley, D. A., Hart, L., Favret, A., Blau, S., Diab, S., Richards, D., Sparano, J., Beck, J. T., Richards, P., Ward, P., Ramaswamy, B., Tsai, M., Blackwell, K., Pluard, T., Tolaney, S. M., Esteva, F. J., Truica, C. I., Alemany, C., Volas-Redd, G., Shtivelband, M. & 4 others, Purkayastha, D., Dalal, A. A., Miller, M. & Hortobagyi, G. N., Aug 2019, In : Clinical breast cancer. 19, 4, p. 268-277.e1

Research output: Contribution to journalArticle

If we build it they will come: targeting the immune response to breast cancer

Gatti-Mays, M. E., Balko, J. M., Gameiro, S. R., Bear, H. D., Prabhakaran, S., Fukui, J., Disis, M. L., Nanda, R., Gulley, J. L., Kalinsky, K., Abdul Sater, H., Sparano, J. A., Cescon, D., Page, D. B., McArthur, H., Adams, S. & Mittendorf, E. A., Dec 1 2019, In : npj Breast Cancer. 5, 1, 37.

Research output: Contribution to journalReview article

Open Access
7 Scopus citations

Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Apr 6 2019, In : The Lancet. 393, 10179, p. 1440-1452 13 p.

Research output: Contribution to journalArticle

Open Access
50 Scopus citations

Letters

Sparano, J. A., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalLetter

Neoadjuvant trastuzumab emtansine and pertuzumab in human epidermal growth factor receptor 2–positive breast cancer: Three-year outcomes from the phase III KristinE study

Hurvitz, S. A., Martin, M., Jung, K. H., Huang, C. S., Harbeck, N., Valero, V., Stroyakovskiy, D., Wildiers, H., Campone, M., Boileau, J. F., Fasching, P. A., Afenjar, K., Spera, G., Lopez-Valverde, V., Song, C., Trask, P., Boulet, T., Sparano, J. A., Fraser Symmans, W., Thompson, A. M. & 1 others, Slamon, D., Sep 1 2019, In : Journal of Clinical Oncology. 37, 25, p. 2206-2216 11 p.

Research output: Contribution to journalArticle

Open Access
22 Scopus citations

Simulation modeling to extend clinical trials of adjuvant chemotherapy guided by a 21-gene expression assay in early breast cancer

Jayasekera, J., Sparano, J. A., Gray, R., Isaacs, C., Kurian, A., O'Neill, S., Schechter, C. B. & Mandelblatt, J., Dec 1 2019, In : JNCI Cancer Spectrum. 3, 4, pkz062.

Research output: Contribution to journalArticle

Open Access

Surveillance after treatment of localized breast cancer: Time for reappraisal?

Sparano, J. A. & Lynn Henry, N., Jan 1 2019, In : Journal of the National Cancer Institute. 111, 4, p. 339-341 3 p.

Research output: Contribution to journalEditorial

Open Access
4 Scopus citations

TAILORx: Questions answered, lessons learned, and remaining knowledge gaps

Sparano, J. A. & Gray, R., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1841-1842 2 p.

Research output: Contribution to journalLetter

3 Scopus citations

Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer

Page, D. B., Bear, H., Prabhakaran, S., Gatti-Mays, M. E., Thomas, A., Cobain, E., McArthur, H., Balko, J. M., Gameiro, S. R., Nanda, R., Gulley, J. L., Kalinsky, K., White, J., Litton, J., Chmura, S. J., Polley, M. Y., Vincent, B., Cescon, D. W., Disis, M. L., Sparano, J. A. & 2 others, Mittendorf, E. A. & Adams, S., Dec 1 2019, In : npj Breast Cancer. 5, 1, 34.

Research output: Contribution to journalReview article

Open Access
3 Scopus citations
2018

Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer

Sparano, J. A., Gray, R. J., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Goetz, M. P., Olson, J. A., Lively, T., Badve, S. S., Saphner, T. J., Wagner, L. I., Whelan, T. J., Ellis, M. J., Paik, S., Wood, W. C., Ravdin, P. M., Keane, M. M. & 10 others, Gomez Moreno, H. L., Reddy, P. S., Goggins, T. F., Mayer, I. A., Brufsky, A. M., Toppmeyer, D. L., Kaklamani, V. G., Berenberg, J. L., Abrams, J. & Sledge, G. W., Jul 12 2018, In : New England Journal of Medicine. 379, 2, p. 111-121 11 p.

Research output: Contribution to journalArticle

454 Scopus citations

Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

Sparano, J., O'Neill, A., Alpaugh, K., Wolff, A. C., Northfelt, D. W., Dang, C. T., Sledge, G. W. & Miller, K. D., Dec 2018, In : JAMA Oncology. 4, 12, p. 1700-1706 7 p.

Research output: Contribution to journalArticle

46 Scopus citations

Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer

Pastoriza, J. M., Karagiannis, G. S., Lin, J., Lanjewar, S., Entenberg, D., Condeelis, J. S., Sparano, J. A., Xue, X., Rohan, T. E. & Oktay, M. H., Oct 1 2018, In : Clinical and Experimental Metastasis. 35, 7, p. 613-623 11 p.

Research output: Contribution to journalArticle

6 Scopus citations

Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: a comparison within one prospective trial AMC034

Tan, C. R. C., Barta, S. K., Lee, J., Rudek, M. A., Sparano, J. A. & Noy, A., Aug 3 2018, In : Leukemia and Lymphoma. 59, 8, p. 1851-1860 10 p.

Research output: Contribution to journalArticle

4 Scopus citations

Double-blind phase III trial of adjuvant chemotherapy withand without bevacizumab in patients with lymph node-positiveand high-risk lymph node-negative breast cancer (E5103)

Miller, K. D., O'Neill, A., Gradishar, W., Hobday, T. J., Goldstein, L. J., Mayer, I. A., Bloom, S., Brufsky, A. M., Tevaarwerk, A. J., Sparano, J. A., Le-Lindqwister, N. A., Hendricks, C. B., Northfelt, D. W., Dang, C. T. & Sledge, G. W., Sep 1 2018, In : Journal of Clinical Oncology. 36, 25, p. 2621-2629 9 p.

Research output: Contribution to journalArticle

13 Scopus citations

E2112: Randomized phase III trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer

Yeruva, S. L. H., Zhao, F., Miller, K. D., Tevaarwerk, A. J., Wagner, L. I., Gray, R. J., Sparano, J. A. & Connolly, R. M., Dec 1 2018, In : npj Breast Cancer. 4, 1, 4.

Research output: Contribution to journalReview article

19 Scopus citations

Effects of radiotherapy in early-stage, low-recurrence risk, hormone-sensitive breast cancer

CISNET-BOLD Collaborative Group , Jan 1 2018, In : Journal of the National Cancer Institute. 110, 12, djy128.

Research output: Contribution to journalArticle

14 Scopus citations

Gene Expression Assays in Early-Stage Breast Cancer

Sparano, J. A., Oct 17 2018, In : Oncology (Williston Park, N.Y.). 32, 10

Research output: Contribution to journalArticle

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Jan 2018, In : The Lancet Oncology. 19, 1, p. 27-39 13 p.

Research output: Contribution to journalArticle

183 Scopus citations

Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer

Anampa, J., Haque, T., Murakhovskaya, I., Wang, Y., Bachiashvili, K., Papazoglu, C., Pradhan, K., Steidl, U. G., Sparano, J. A. & Verma, A., Feb 28 2018, In : Haematologica. 103, 3, p. e98-e102

Research output: Contribution to journalLetter

1 Scopus citations

Neoadjuvant systemic therapy for breast cancer searching for more effectively curative therapies

Sparano, J. A., Mar 2018, In : JAMA Oncology. 4, 3, p. 293-294 2 p.

Research output: Contribution to journalEditorial

3 Scopus citations

Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial

Hurvitz, S. A., Martin, M., Symmans, W. F., Jung, K. H., Huang, C. S., Thompson, A. M., Harbeck, N., Valero, V., Stroyakovskiy, D., Wildiers, H., Campone, M., Boileau, J. F., Beckmann, M. W., Afenjar, K., Fresco, R., Helms, H. J., Xu, J., Lin, Y. G., Sparano, J. & Slamon, D., Jan 2018, In : The Lancet Oncology. 19, 1, p. 115-126 12 p.

Research output: Contribution to journalArticle

87 Scopus citations

Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer

Anampa, J., Chen, A., Wright, J., Patel, M., Pellegrino, C., Fehn, K., Sparano, J. A. & Andreopoulou, E., Feb 2018, In : Clinical breast cancer. 18, 1, p. e135-e142

Research output: Contribution to journalArticle

4 Scopus citations

Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial

Kalinsky, K., Sparano, J. A., Zhong, X., Andreopoulou, E., Taback, B., Wiechmann, L., Feldman, S. M., Ananthakrishnan, P., Ahmad, A., Cremers, S., Sireci, A. N., Cross, J. R., Marks, D. K., Mundi, P., Connolly, E., Crew, K. D., Maurer, M. A., Hibshoosh, H., Lee, S. & Hershman, D. L., Nov 1 2018, In : Clinical and Translational Oncology. 20, 11, p. 1474-1483 10 p.

Research output: Contribution to journalArticle

9 Scopus citations

Prognostic gene expression assays in breast cancer: are two better than one?

Sparano, J. A., Dec 1 2018, In : npj Breast Cancer. 4, 1, 11.

Research output: Contribution to journalEditorial

2 Scopus citations

Randomized phase II trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: Results of PrE0102

Kornblum, N., Zhao, F., Manola, J., Klein, P., Ramaswamy, B., Brufsky, A., Stella, P. J., Burnette, B., Telli, M., Makower, D. F., Cheema, P., Truica, C. I., Wolff, A. C., Soori, G. S., Haley, B., Wassenaar, T. R., Goldstein, L. J., Miller, K. D. & Sparano, J. A., Jun 1 2018, In : Journal of Clinical Oncology. 36, 16, p. 1556-1563 8 p.

Research output: Contribution to journalArticle

35 Scopus citations

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies

Rakovitch, E., Gray, R., Baehner, F. L., Sutradhar, R., Crager, M., Gu, S., Nofech-Mozes, S., Badve, S. S., Hanna, W., Hughes, L. L., Wood, W. C., Davidson, N. E., Paszat, L., Shak, S., Sparano, J. A. & Solin, L. J., Jun 1 2018, In : Breast Cancer Research and Treatment. 169, 2, p. 359-369 11 p.

Research output: Contribution to journalArticle

11 Scopus citations

Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas

AIDS Malignancy Consortium, Dec 26 2018, In : Blood Advances. 2, 24, p. 3618-3626 9 p.

Research output: Contribution to journalArticle

1 Scopus citations

Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075)

Ramos, J. C., Sparano, J. A., Rudek, M. A., Moore, P. C., Cesarman, E., Reid, E. G., Henry, D., Ratner, L., Aboulafia, D., Lee, J. Y., Ambinder, R. F., Mitsuyasu, R. & Noy, A., Mar 2018, In : Clinical Lymphoma, Myeloma and Leukemia. 18, 3, p. 180-190.e2

Research output: Contribution to journalArticle

4 Scopus citations

Simulation modeling of cancer clinical trials: Application to omitting radiotherapy in low-risk breast cancer

CISNET-BOLD Collaborative Group , 2018, In : Journal of the National Cancer Institute. 110, 12, djy059.

Research output: Contribution to journalArticle

4 Scopus citations
2017

A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104)

Goldstein, L. J., Zhao, F., Wang, M., Swaby, R. F., Sparano, J. A., Meropol, N. J., Bhalla, K. N., Pellegrino, C. M., Katherine Alpaugh, R., Falkson, C. I., Klein, P. & Sledge, G. W., Jun 16 2017, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-8 8 p.

Research output: Contribution to journalArticle

6 Scopus citations

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research

Hendry, S., Salgado, R., Gevaert, T., Russell, P. A., John, T., Thapa, B., Christie, M., Van De Vijver, K., Estrada, M. V., Gonzalez-Ericsson, P. I., Sanders, M., Solomon, B., Solinas, C., Van Den Eynden, G. G. G. M., Allory, Y., Preusser, M., Hainfellner, J., Pruneri, G., Vingiani, A., Demaria, S. & 80 others, Symmans, F., Nuciforo, P., Comerma, L., Thompson, E. A., Lakhani, S., Kim, S. R., Schnitt, S., Colpaert, C., Sotiriou, C., Scherer, S. J., Ignatiadis, M., Badve, S., Pierce, R. H., Viale, G., Sirtaine, N., Penault-Llorca, F., Sugie, T., Fineberg, S., Paik, S., Srinivasan, A., Richardson, A., Wang, Y., Chmielik, E., Brock, J., Johnson, D. B., Balko, J., Wienert, S., Bossuyt, V., Michiels, S., Ternes, N., Burchardi, N., Luen, S. J., Savas, P., Klauschen, F., Watson, P. H., Nelson, B. H., Criscitiello, C., O'Toole, S., Larsimont, D., De Wind, R., Curigliano, G., André, F., Lacroix-Triki, M., Van De Vijver, M., Rojo, F., Floris, G., Bedri, S., Sparano, J., Rimm, D., Nielsen, T., Kos, Z., Hewitt, S., Singh, B., Farshid, G., Loibl, S., Allison, K. H., Tung, N., Adams, S., Willard-Gallo, K., Horlings, H. M., Gandhi, L., Moreira, A., Hirsch, F., Dieci, M. V., Urbanowicz, M., Brcic, I., Korski, K., Gaire, F., Koeppen, H., Lo, A., Giltnane, J., Rebelatto, M. C., Steele, K. E., Zha, J., Emancipator, K., Juco, J. W., Denkert, C., Reis-Filho, J., Loi, S. & Fox, S. B., 2017, In : Advances in Anatomic Pathology. 24, 5, p. 235-251 17 p.

Research output: Contribution to journalReview article

112 Scopus citations

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

Hendry, S., Salgado, R., Gevaert, T., Russell, P. A., John, T., Thapa, B., Christie, M., Van De Vijver, K., Estrada, M. V., Gonzalez-Ericsson, P. I., Sanders, M., Solomon, B., Solinas, C., Van Den Eynden, G. G. G. M., Allory, Y., Preusser, M., Hainfellner, J., Pruneri, G., Vingiani, A., Demaria, S. & 80 others, Symmans, F., Nuciforo, P., Comerma, L., Thompson, E. A., Lakhani, S., Kim, S. R., Schnitt, S., Colpaert, C., Sotiriou, C., Scherer, S. J., Ignatiadis, M., Badve, S., Pierce, R. H., Viale, G., Sirtaine, N., Penault-Llorca, F., Sugie, T., Fineberg, S., Paik, S., Srinivasan, A., Richardson, A., Wang, Y., Chmielik, E., Brock, J., Johnson, D. B., Balko, J., Wienert, S., Bossuyt, V., Michiels, S., Ternes, N., Burchardi, N., Luen, S. J., Savas, P., Klauschen, F., Watson, P. H., Nelson, B. H., Criscitiello, C., O'Toole, S., Larsimont, D., De Wind, R., Curigliano, G., André, F., Lacroix-Triki, M., Van De Vijver, M., Rojo, F., Floris, G., Bedri, S., Sparano, J., Rimm, D., Nielsen, T., Kos, Z., Hewitt, S., Singh, B., Farshid, G., Loibl, S., Allison, K. H., Tung, N., Adams, S., Willard-Gallo, K., Horlings, H. M., Gandhi, L., Moreira, A., Hirsch, F., Dieci, M. V., Urbanowicz, M., Brcic, I., Korski, K., Gaire, F., Koeppen, H., Lo, A., Giltnane, J., Rebelatto, M. C., Steele, K. E., Zha, J., Emancipator, K., Juco, J. W., Denkert, C., Reis-Filho, J., Loi, S. & Fox, S. B., 2017, In : Advances in Anatomic Pathology. 24, 6, p. 311-335 25 p.

Research output: Contribution to journalReview article

126 Scopus citations

Cetuximab plus chemoradiotherapy for HIV-associated anal carcinoma: A phase II AIDS malignancy consortium trial

Sparano, J. A., Lee, J. Y., Palefsky, J., Henry, D. H., Wachsman, W., Rajdev, L., Aboulafia, D., Ratner, L., Fitzgerald, T. J., Kachnic, L. & Mitsuyasu, R., Mar 1 2017, In : Journal of Clinical Oncology. 35, 7, p. 727-733 7 p.

Research output: Contribution to journalArticle

29 Scopus citations